iBET @ a glance
iBET is a private not for profit research intensive SME in the area of biotechnology and life sciences. We bridge university and industry research, by establishing partnerships particularly in the areas of health-pharma, agro-industry, forestry, agriculture and the environment.
iBET has three satellite laboratories with Novartis, Bayer Healthcare and Merck Serono. Our network of collaborations is broad, ranging from national and international companies, research institutes, foundations and public institutions. At iBET we serve also as an incubation platform for start-up/spin-off companies.
iBET is a certified service provider. Our Analytical Service Unit is certified with Good Manufacturing Practices (GMP), and our pilot plant unit (2.400m2) provides process development technology and manufacturing services.
Our partner GenIbet Biopharmaceuticals (45% owned by iBET) follows current Good Manufacturing Practices, in early stage biopharmaceuticals production for phase I and Phase II clinical trials.
iBET belongs to the Associated Laboratory of Oeiras (Laboratório Associado de Oeiras, LAO) along with Instituto de Tecnologia Química e Biológica (ITQB), Instituto Gulbenkian de Ciência (IGC) and the Chronic Diseases Research Center (CEDOC).
Since 2015 iBET became the coordinator of a Research Unit funded by Fundação para a Ciência e Tecnologia (FCT), iNOVA4Health, a translational medicine program organizing the efforts of biomedical researchers involved in biological understanding of disease, lead compounds and biopharmaceuticals “pre-discovery”, technological scientists involved in “preclinical development”, and clinicians involved in “early clinical and first in man clinical trials” from institutions within NOVA University of Lisbon.
Our institute has a privileged location only 15 Km west of Lisbon on the coast with easy and close access to main transportation routes to Lisbon (by train and highway).
You can find directions to iBET here.